BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6763142)

  • 1. The sympathetic nervous system in primary hypertension.
    Weber MA; Drayer JI
    Miner Electrolyte Metab; 1982 Feb; 7(2):57-66. PubMed ID: 6763142
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic activity in essential hypertension.
    Koch-Weser J
    N Engl J Med; 1973 Mar; 288(12):627-9. PubMed ID: 4405674
    [No Abstract]   [Full Text] [Related]  

  • 3. Sympathetic nerve and hormonal responses to a single dose of nifedipine in patients with essential hypertension and normal subjects: comparison among renin-subgroups.
    Oemar H; Kubo S; Masaoka S; Kanazawa I; Yuasa A; Tsuchioka Y; Matsuura H; Kurogane H; Kajiyama G
    Hiroshima J Med Sci; 1983 Jun; 32(2):187-97. PubMed ID: 6352568
    [No Abstract]   [Full Text] [Related]  

  • 4. [The renin-angiotensin system and the sympathetic nervous system in essential hypertension].
    Vincent M; Milon H; Revol T; Annat G; Froment A; Sassard J; Cier JF
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():91-4. PubMed ID: 6810836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the sympathetic system in the maintenance of human hypertension.
    de Champlain J; Cousineau D; Lapointe L
    Clin Invest Med; 1978; 1(3-4):123-8. PubMed ID: 42501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 8. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension].
    Nami R; Martinelli M; Panza F; Pavese G; Carletti F; Buracchi P; Lucani B; Pazzaglia A; Saia F; Gennari C
    Minerva Cardioangiol; 1993 Sep; 41(9):387-95. PubMed ID: 8259235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
    Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
    Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships of the renin angiotensin system and the sympathetic nervous system in the pathogenesis of hypertension in man-a hypothesis.
    Doyle AE; Louis WJ; Wilson M
    Clin Exp Pharmacol Physiol; 1975; Suppl 2():141-4. PubMed ID: 1183082
    [No Abstract]   [Full Text] [Related]  

  • 11. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M; Coletta E; Leenen FH
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in the elderly.
    Niarchos AP; Laragh JH
    Mod Concepts Cardiovasc Dis; 1980 Aug; 49(8):43-8. PubMed ID: 6993914
    [No Abstract]   [Full Text] [Related]  

  • 13. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):1996-8; discussion 2016. PubMed ID: 20185633
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive drugs and the sympathetic nervous system.
    Del Colle S; Morello F; Rabbia F; Milan A; Naso D; Puglisi E; Mulatero P; Veglio F
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):487-96. PubMed ID: 18030057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of the sympathetic-adrenal system and blood renin level in adolescents with primary arterial hypertension].
    Markov KhM; Nebol'sina LI; Pinelis VG
    Vrach Delo; 1974 Aug; 0(8):9-13. PubMed ID: 4408477
    [No Abstract]   [Full Text] [Related]  

  • 16. Sympathetic neural activity in hypertension and related diseases.
    Grassi G
    Am J Hypertens; 2010 Oct; 23(10):1052-60. PubMed ID: 20651696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of the sympathetic nervous system in the pathogenesis of hypertension.
    Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(4):S57-9. PubMed ID: 3868712
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurogenic factors in low renin essential hypertension.
    Campese VM; Myers MR; DeQuattro V
    Am J Med; 1980 Jul; 69(1):83-91. PubMed ID: 6992576
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered plasma leucine-enkephalin concentrations in patients with established hypertension.
    Kraft K; Kokorsch F; Diehl J; Kolloch R; Stumpe KO
    Prog Clin Biol Res; 1990; 328():367-70. PubMed ID: 2304957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.